-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disabilities-quality-improvement-outcomes_research-protocol.pdf
August 03, 2011 - Uncontrolled diabetes
o Diabetes complications
o Bacterial pneumonia
o Asthma
o Gastroenteritis
o Hypertension
-
effectivehealthcare.ahrq.gov/products/antipsychotics/research-protocol
September 06, 2018 - (e.g., population, age, sex, presence of dementia, setting, presence of substance use, presence of hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/bariatric-surgery-trends_research.pdf
November 01, 2012 - significant improve-
ments in medical comorbidities such as type 2 diabetes, obstructive
sleep apnea, and hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tech-brief-healthcare-system-strategies-protocol-final.pdf
May 18, 2022 - or cardiovascular disease* or chronic obstructive
pulmonary disease or COPD or diabetes or HIV or hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper.pdf
September 01, 2015 - Pharmacotherapy for hypertension in the
elderly. Cochrane Database Syst Rev.
2009(4):CD000028.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tech-brief-31-mobile-applications-self-mgmt-disposition-comments.pdf
May 08, 2018 - Enhancing Diabetes and Hypertension Self-Management: A Randomized Trial of a Mobile Phone Strategy.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/delirium-research-protocol.pdf
June 01, 2018 - e.g., population,
age, sex, presence of dementia, setting, presence of substance use, presence of
hypertension
-
effectivehealthcare.ahrq.gov/products/alternative-payment-models
-
effectivehealthcare.ahrq.gov/sites/default/files/cer-236-maternal-fetal-child-outcomes-disposition-comments.pdf
April 15, 2021 - For example, a relatively recent review estimated a
NNH of 1,000 for persistent pulmonary hypertension … reuptake inhibitors and serotonin
norepinephrine reuptake inhibitors and risk for
persistent pulmonary hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/2020-epc-year-in-review.pdf
January 01, 2020 - Oral glucocorticoids and incident treatment of diabetes mellitus, hypertension, and venous
thromboembolism
-
effectivehealthcare.ahrq.gov/products/copd/protocol
October 10, 2018 - Comorbidities (tobacco abuse, pulmonary hypertension, congestive heart failure, morbid obesity, gastroesophageal
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-artery-disease-testing_research-protocol.pdf
January 15, 2015 - years old, male < 55 years old)
• Negative family history for CAD
• < 2 CAD risk factors (including hypertension … years old, male ≥ 55 years old)
• Positive family history for CAD
• ≥ 2 CAD risk factors (including hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
June 01, 2012 - Example: The implications of testing for carotid arterial stenosis are changing as hypertension treatment … As an example, improvements in the treatment of hypertension and hyperlipidemia may change the implications
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/atrial-fibrillation_research-protocol.pdf
May 22, 2012 - Patients at high risk for stroke and bleeding events (e.g., patients with
diabetes, heart failure, and hypertension … Patients at high risk for stroke and bleeding
events (patients with diabetes, heart failure, and
hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
June 01, 2012 - Example: The implications of testing for carotid arterial stenosis are changing as hypertension treatment … As an example, improvements in the treatment of hypertension and hyperlipidemia may change the implications
-
effectivehealthcare.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Riociguat (Adempas) for treatment of pulmonary artery hypertension No high-impact potential at this time … end-stage heart failure (HF) or address valve problems, arrhythmias, stroke, and
treatment-resistant hypertension … Eligible Topic Deemed Not High-Impact
Riociguat (Adempas) for treatment of pulmonary artery hypertension … is a soluble guanylate cyclase stimulator intended for
treating patients who have pulmonary artery hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gestational-diabetes-screening-diagnosis_disposition-comments.pdf
January 01, 2020 - .:'... 1.75 risk of LGA... or 1.4
risk for pregnancy hypertension...' … Contraindications to exercise during pregnancy
may include but are not limited to: pregnancy-
induced hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-treatment_executive.pdf
August 01, 2012 - time CAD is diagnosed, women are more likely
to have comorbid factors such as diabetes mellitus,
hypertension … also occur in patients with valvular heart
disease, hypertrophic cardiomyopathy, and uncontrolled
hypertension … presentation—should receive aggressive management of
risk factors for progression of atherosclerosis (smoking,
hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2020.pdf
January 01, 2020 - Oral glucocorticoids and incident treatment of diabetes mellitus, hypertension, and venous
thromboembolism
-
effectivehealthcare.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
April 17, 2012 - major contributor to many
diseases including blood clots, coronary artery disease, dyslipidemia, hypertension … kg/m
2
or
more or a BMI ≥kg/m
2
with comorbid obesity-related risk factors or diseases (such as hypertension